Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Method Using DNA Nanoballs to Revolutionize Pathogen Detection

By LabMedica International staff writers
Posted on 08 Sep 2023

Throughout the recent COVID-19 pandemic, protein-based diagnostics played a significant role in rapid testing. More...

However, developing high-quality antibodies for these methods is time-consuming. In contrast, nucleic acid-based approaches offer advantages in terms of development ease, sensitivity, and flexibility. Scientists have now pioneered a novel technique using DNA Nanoballs for pathogen detection that could simplify nucleic acid testing and revolutionize pathogen identification. Their research could pave the way for a simple electronic-based test to quickly and affordably identify various nucleic acids in diverse scenarios.

The methodology developed by researchers at Karolinska Institute (Stockholm, Sweden) combined Molecular Biology (specifically DNA Nanoball generation) with electronics (electric impedance-based quantification) to create this groundbreaking detection tool. They are cautiously optimistic about its potential to identify a range of pathogenic agents in real-world settings. The team modified an isothermal DNA amplification reaction called LAMP to produce tiny DNA nanoballs measuring 1-2μM if the pathogen was present in the sample. These nanoballs are then guided through tiny channels and electrically identified as they pass between two electrodes. The method has demonstrated impressive sensitivity, capable of detecting as few as 10 target molecules, and provides rapid results in under an hour using a compact, stationary system.

This label-free detection method has the potential to accelerate the development of new diagnostic kits. By combining affordable mass-produced electronics with lyophilized reagents, it could become a cost-effective, widely accessible, and scalable point-of-care device. Currently, the research team is actively exploring applications in fields such as environmental monitoring, food safety, virus detection, and antimicrobial resistance testing. They are also considering licensing options and establishing a startup to leverage this technology, having recently applied for a patent.

“Fast and accurate detection of genetic material is key for diagnosis, especially so in response to the emergence of novel pathogens,” said principal investigator Vicent Pelechano.

Related Links:
Karolinska Institute 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Automated Urinalysis Solution
UN-9000
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.